ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「菌状息肉症・セザリー症候群、同種幹細胞移植の紹介基準と時期を米国専門家が初めて合意」の検索結果

20 件中 10 件を表示 (3782 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("mycosis fungoides"[MeSH] OR "Sezary syndrome"[MeSH]) AND ("hematopoietic stem cell transplantation"[MeSH] OR "allogeneic stem cell transplantation" OR allogeneic transplantation) AND (criteria OR guidelines OR consensus OR recommendations OR timing OR indications)

💡 菌状息肉症とセザリー症候群のMeSH用語、同種幹細胞移植関連用語、紹介基準・時期に関するキーワードを組み合わせた検索式

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.

    Johanna Latzka, Chalid Assaf, Martine Bagot 他 · European journal of cancer (Oxford, England : 1990) · 2023

    On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 and 2017 this document provides an updated standard for the treatment of mycosis fungoides and Sézary syndrome (MF/SS). It considers recent relevant publications and treatment options introduced into clinical practice after 2017. Consensus was established among the authors th…

    📄 PubMed で読む (PMID: 37890355)
  • Therapeutic advances for cutaneous T-cell lymphoma.

    Martine Bagot · The British journal of dermatology · 2025

    Cutaneous T-cell lymphomas (CTCLs) are a group of rare and heterogenous diseases. There is currently no curative treatment for patients with advanced mycosis fungoides (MF) and Sézary syndrome (SS). The European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of MF/SS have been updated and focus on recently available treatments. Peginterferon, a new fo…

    📄 PubMed で読む (PMID: 40131851)
  • Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.

    Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff 他 · Lancet (London, England) · 2023

    Advanced-stage cutaneous T-cell lymphomas (CTCLs) are rare, usually refractory, and fatal diseases. Case series have suggested that allogeneic haematopoietic stem cell transplantation (HSCT) might improve the prognosis of advanced-stage CTCLs. The objective of this study was to investigate the effect of allogeneic HSCT compared with non-HSCT therapy on the outcome of individuals with advanced-stag…

    📄 PubMed で読む (PMID: 37105210)
  • Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.

    William T Johnson, Reetu Mukherji, Saritha Kartan 他 · Chinese clinical oncology · 2019

    Mycosis fungoides and Sézary syndrome encompass over 70% of all cases of cutaneous T-cell lymphoma (CTCL). While early stage disease has excellent long-term survival rates, advanced stage disease (IIB-IV) carries a poor prognosis with a median 5-year overall survival rate of approximately 50%. Early stage and advanced stage disease have different treatment algorithms with systemic therapy being in…

    📄 PubMed で読む (PMID: 30525754)
  • Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee.

    Gandhi Damaj, Adèle de Masson, Peter Dreger 他 · Bone marrow transplantation · 2025

    This manuscript provides expert recommendations on the role of allogeneic hematopoietic cell transplantation (allo-HCT) for cutaneous T-cell lymphoma (CTCL), specifically Mycosis Fungoides (MF) and Sezary Syndrome (SS). Critical aspects such as patient selection, timing, and bridging therapy are addressed, as well as donor source, conditioning regimens and post-transplant management. These consens…

    📄 PubMed で読む (PMID: 41034407)
  • ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.

    Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja 他 · Journal of the American Academy of Dermatology · 2025

    Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. While MF generally follows an indolent course, a subset of patients will experience progressive and/or treatment-refractory disease. SS is an aggressive cutaneous T-cell lymphoma associated with high morbidity and mortality secondary to immune compromise and opportunistic infection. Although …

    📄 PubMed で読む (PMID: 40199382)
  • ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

    Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja 他 · Transplantation and cellular therapy · 2024

    Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). While MF generally follows an indolent course, a subset of patients will experience progressive and/or treatment-refractory disease; Sézary syndrome is an aggressive lymphoma associated with high morbidity and mortality. Although allogeneic hematopoietic cell transplant (allo-HCT) is t…

    📄 PubMed で読む (PMID: 39222792)
  • Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome.

    Takehiko Mori, Souichi Shiratori, Junji Suzumiya 他 · Hematological oncology · 2020

    Although allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to provide prolonged remission of relapsed/refractory mycosis fungoides (MF) and Sézary syndrome (SS), its role has not been fully evaluated. Here, the outcomes of allogeneic HSCT for patients with MF/SS were retrospectively evaluated by using the registry database of the Japan Society for Hematopoietic Cell Trans…

    📄 PubMed で読む (PMID: 32011008)
  • Mechanism of action of chlormethine gel in mycosis fungoides.

    E Guenova, P L Ortiz-Romero, B Poligone 他 · Journal of the European Academy of Dermatology and Venereology : JEADV · 2023

    Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by proliferation of malignant skin-tropic T cells. Progression from early-stage disease (skin patches and/or plaques) to more advanced stages (cutaneous tumours, erythroderma or extracutaneous involvement) occurs slowly and can be discontinuous. Prognosis is poor for the ~25% of patients who progress to adv…

    📄 PubMed で読む (PMID: 37262305)
  • Discussion on the indication of allogeneic stem cell transplantation for advanced cutaneous T cell lymphomas.

    Silvana Novelli, Anna Monter, M Pilar García-Muret 他 · International journal of hematology · 2019

    Advanced cutaneous T cell lymphoma (CTCL) patients have a dismal prognosis, especially those relapsing or progressing after systemic therapy. No curative therapies are available, but some new agents have prolonged disease-free survival time with a good toxicity profile. Allogeneic stem cell transplantation (allo-SCT) offers the longest disease-free survival, potentially representing the best thera…

    📄 PubMed で読む (PMID: 31317515)